Mesoblast Ltd (MSB)

Sydney


Symbol		Exchange		Currency
MSB	·	Sydney	·	AUD	Delayed
MESO	·	NASDAQ	·	USD	Real-time
MEOBF	·	OTC Markets	·	USD	Delayed

Currency in AUD

MSB Pro Research

2.460

+0.050(+2.07%)

Closed·28/08

Fair Value

Unlock Value

Day's Range

2.360

2.540

52 wk Range

1.880

3.310

MSB Income Statement

Assess the Mesoblast income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the MSB net worth.

Period Ending:

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

2025

30/06

2026

30/06

Total Revenues

aa.aa

10.21

7.5

5.9

17.2

120.25

Total Revenues Growth

aa.aa

+37.36%

-26.54%

-21.32%

+191.39%

+599.21%

Cost Of Revenues

aa.aa

63.57

52.82

2.95

17.62

24.03

Gross Profit

aa.aa

-53.36

-45.32

2.95

-0.42

96.22

Gross Profit Growth

aa.aa

+31.85%

+15.08%

+106.51%

-114.19%

+23,064.68%

Gross Profit Margin %

aa.aa

-522.58%

-604.12%

50.02%

-2.44%

80.02%

Other Operating Expenses, Total

aa.aa

27.21

23.97

61.01

62.02

147.47

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-11.64%	-11.9%	+154.5%	+1.66%	+137.77%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	36.77	22.32	90.15
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	27.21	27.48	24.98	39.31	57.35
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0	-3.51	-0.73	0.4	-0.02

Operating Income

aa.aa

-80.57

-69.29

-58.06

-62.44

-51.25

Operating Income Growth

aa.aa

+26.14%

+14.01%

+16.2%

-7.55%

+17.93%

EBIT Margin %

aa.aa

-789.09%

-923.73%

-983.77%

-363.08%

-42.62%

Net Interest Expenses

aa.aa

-16.9

-18.61

-20.3

-18.2

-15.96

Net Interest Expenses Growth

aa.aa

-6.19%

-10.12%

-9.05%

+10.34%

+12.31%

Interest Expense, Total

aa.aa

-16.91

-19.44

-20.66

-21.75

-19.87

Interest And Investment Income

aa.aa

0.83

0.36

3.55

3.91

Other Non Operating Expenses, Total

aa.aa

4.98

-3.05

-0.4

-6.28

-2.04

EBT, Excl. Unusual Items

aa.aa

-92.5

-90.95

-78.76

-86.93

-69.25

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

0.91

8.85

-9.39

-14.89

12.36

EBT, Incl. Unusual Items

aa.aa

-91.59

-82.1

-88.15

-101.81

-56.89

EBT, Incl. Unusual Items Growth

aa.aa

+8.07%

+10.36%

-7.36%

-15.5%

+44.13%

EBT, Incl. Unusual Items Margin

aa.aa

-896.93%

-1,094.53%

-1,493.51%

-592%

-47.31%

Income Tax Expense

aa.aa

-0.24

-0.21

-0.19

0.33

0.61

Net Income to Company

aa.aa

-91.35

-81.89

-87.96

-102.14

-57.5

Minority Interest

aa.aa

Net Income

aa.aa

-91.35

-81.89

-87.96

-102.14

-57.5

Net Income Growth

aa.aa

+7.55%

+10.35%

-7.41%

-16.13%

+43.71%

Net Income Margin %

aa.aa

-894.59%

-1,091.71%

-1,490.27%

-593.92%

-47.82%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-91.35

-81.89

-87.96

-102.14

-57.5

Basic EPS - Continuing Operations

aa.aa

-0.13

-0.11

-0.09

-0.08

-0.04

Basic EPS - Continuing Operations Growth

aa.aa

+18.09%

+21.29%

+15.34%

+5.13%

+47.49%

Diluted EPS - Continuing Operations

aa.aa

-0.13

-0.11

-0.09

-0.08

-0.04

Diluted EPS - Continuing Operations Growth

aa.aa

+18.07%

+21.3%

+15.34%

+5.09%

+47.51%

Basic Weighted Average Shares Outstanding

aa.aa

682.86

777.72

986.7

1,207.79

1,294.87

Diluted Weighted Average Shares Outstanding

aa.aa

682.86

777.72

986.7

1,207.79

1,294.87

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-77.91

-66.84

-56.17

-58.18

-45.01

EBITDA Growth

aa.aa

+26.86%

+14.21%

+15.97%

-3.59%

+22.65%

EBITDA Margin %

aa.aa

-763.01%

-891.12%

-951.66%

-338.31%

-37.43%

EBIT

aa.aa

-80.57

-69.29

-58.06

-62.44

-51.25

* In Millions of USD (except for per share items)

FAQ

What was Mesoblast’s revenue at year end?

At the end of the last reported fiscal year, Mesoblast (MSB) recorded total revenue of 120.250 million USD.

How much revenue did Mesoblast report in the most recent quarter?

In its most recent quarterly earnings report, Mesoblast posted revenue of 68.908 million USD.

What was Mesoblast’s net income for the year?

For the full year, Mesoblast reported net income of -57.500 million USD.

How much net income did Mesoblast post in the last quarter?

In the most recent quarter, Mesoblast (MSB) posted net income of -17.338 million USD.

What was Mesoblast’s gross profit for the year?

Gross profit for the year was reported at 96.223 million USD.

How much gross profit did Mesoblast generate last quarter?

Mesoblast recorded gross profit of 98.647 million USD in its latest quarterly report.

What was Mesoblast’s annual operating income?

For the full year, Mesoblast (MSB) reported operating income of -51.250 million USD.

What was Mesoblast’s operating income last quarter?

Quarterly operating income was -22.931 million USD.

What was Mesoblast’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -19.939 million USD.

What was the quarter-over-quarter change in EBITDA for Mesoblast?

EBITDA changed by 20.454% million USD compared to the last quarter.

What is Mesoblast’s most recent gross profit margin?

The latest reported gross profit margin for Mesoblast (MSB) is 143.157% million USD.

What is Mesoblast’s most recent net income margin?

Net income margin based on recent financials is -25.161% million USD.

What is Mesoblast’s most recent EBIT margin?

Mesoblast reported an EBIT margin of -33.278% million USD based on current figures.

How did Mesoblast’s revenue change compared to the previous quarter?

Revenue changed by 34.214% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Mesoblast?

In the latest quarter, gross profit changed by 4,169.592% million USD from the previous quarter.

S&P/TSX

36,553.92

-280.33

-0.76%

S&P/TSX 60

2,144.24

-11.04

-0.51%

US 30

53,554.90

-13.7

-0.03%

US 500

7,712.30

-18.5

-0.24%

S&P 500 VIX

14.43

-0.08

-0.55%

DAX

26,569.99

+202.75

+0.77%

Dollar Index

99.64

+0.540

+0.55%

Market Movers

Name	Last	Chg. %	Vol.
Suncor Energy	91.09	-1.09%	10.53M
RBC	284.17	+0.25%	3.15M
Canadian Natural	68.14	-1.29%	12.70M
Bank of Montreal	239.23	+0.23%	3.41M
Enbridge	69.76	+0.69%	7.22M
Bank of Nova Scotia	128.36	-0.37%	3.89M
Toronto Dominion Bank	168.61	+0.46%	2.24M

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Regenera Insights	0.02	+100.00%	3.00K
Martello Tech	0.0100	+100.00%	17.70K
1933 Industries	0.0100	+100.00%	102.00K
LFNT Resources	0.20	+90.48%	17.50K

Name	Last	Chg. %	Vol.
Global Health Clinics	0.055	-80.00%	500.00
Patriot Gold	0.01	-76.92%	10.02K
Patriot Gold	0.02	-76.92%	10.02K
CardioComm Solutions Inc.	0.0050	-50.00%	1.00K
EnviroMetal Technologies	0.01	-50.00%	1.46K
Ramm Pharma	0.01	-50.00%	1.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Equinox Gold	18.07	-3.06%	3.64M
Toronto Dominion Bank	168.61	+0.46%	2.24M
Keel Infra	4.49	-7.80%	5.67M
Celestica Inc.	415.52	-5.51%	243.83K
TELUS	13.46	-0.59%	5.41M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaa A	34.86	+55.77%	54.30
Aaaaaaaaaa	8.78	+49.70%	13.14
Aaaaaaaaa Aaaaaa	119.95	+48.13%	177.68
Aaa A Aaaaaaa Aa	7.85	+45.80%	11.45
Aaaaaa	29.45	+45.61%	42.88
Aaa Aaaaaa Aa	5.42	+44.04%	7.81
A Aaaa A A	103.85	+43.87%	149.41

Name	Last	Upside	Fair Value
Aaaaaaa A	34.86	+55.77%	54.30
Aaaaaaaaaa	8.78	+49.70%	13.14
Aaaaaaaaa Aaaaaa	119.95	+48.13%	177.68
Aaa A Aaaaaaa Aa	7.85	+45.80%	11.45
Aaaaaa	29.45	+45.61%	42.88
Aaa Aaaaaa Aa	5.42	+44.04%	7.81
A Aaaa A A	103.85	+43.87%	149.41

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Mesoblast Ltd (MSB)

MSB Income Statement

FAQ

What was Mesoblast’s revenue at year end?

How much revenue did Mesoblast report in the most recent quarter?

What was Mesoblast’s net income for the year?

How much net income did Mesoblast post in the last quarter?

What was Mesoblast’s gross profit for the year?

How much gross profit did Mesoblast generate last quarter?

What was Mesoblast’s annual operating income?

What was Mesoblast’s operating income last quarter?

What was Mesoblast’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Mesoblast?

What is Mesoblast’s most recent gross profit margin?

What is Mesoblast’s most recent net income margin?

What is Mesoblast’s most recent EBIT margin?

How did Mesoblast’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Mesoblast?

Trending Stocks